These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33121512)

  • 1. Corticosteroids in severe COVID-19: a critical view of the evidence.
    De Backer D; Azoulay E; Vincent JL
    Crit Care; 2020 Oct; 24(1):627. PubMed ID: 33121512
    [No Abstract]   [Full Text] [Related]  

  • 2. WHO recommends corticosteroids for patients with severe or critical COVID-19.
    Keyt H
    Ann Intern Med; 2021 Jan; 174(1):JC2. PubMed ID: 33395337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
    Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
    CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 pneumonia: do not leave the corticosteroids behind!
    Pinna SM; Scabini S; Corcione S; Lupia T; De Rosa FG
    Future Microbiol; 2021 Mar; 16():317-322. PubMed ID: 33709775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis.
    Wang J; Yang W; Chen P; Guo J; Liu R; Wen P; Li K; Lu Y; Ma T; Li X; Qin S; Zhang Y; Wang Y
    PLoS One; 2021; 16(4):e0249481. PubMed ID: 33882090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials.
    Pasin L; Navalesi P; Zangrillo A; Kuzovlev A; Likhvantsev V; Hajjar LA; Fresilli S; Lacerda MVG; Landoni G
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):578-584. PubMed ID: 33298370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid administration for viral pneumonia: COVID-19 and beyond.
    Yang JW; Yang L; Luo RG; Xu JF
    Clin Microbiol Infect; 2020 Sep; 26(9):1171-1177. PubMed ID: 32603802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19.
    Arabi YM; Chrousos GP; Meduri GU
    Intensive Care Med; 2020 Nov; 46(11):2067-2070. PubMed ID: 33026460
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of tocilizumab treatment in severely ill COVID-19 patients.
    Zhao J; Cui W; Tian BP
    Crit Care; 2020 Aug; 24(1):524. PubMed ID: 32854738
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.
    Li H; Chen C; Hu F; Wang J; Zhao Q; Gale RP; Liang Y
    Leukemia; 2020 Jun; 34(6):1503-1511. PubMed ID: 32372026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do we decide to de-isolate COVID-19 patients?
    Liao CH; Hung SC; Lee YT; Hung HC; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):386-388. PubMed ID: 32299784
    [No Abstract]   [Full Text] [Related]  

  • 13. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.
    Cotter A; Wallace D; McCarthy C; Feeney E; O'Neill L; Stack J; McCarthy G; Hussain R; Alvarez Barco E; Doran P; Mallon P
    Trials; 2020 Sep; 21(1):758. PubMed ID: 32883328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of systematic corticosteroids among severe COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials.
    Ma S; Xu C; Liu S; Sun X; Li R; Mao M; Feng S; Wang X
    Signal Transduct Target Ther; 2021 Feb; 6(1):83. PubMed ID: 33612824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audio Interview: Dexamethasone and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jul; 383(4):e52. PubMed ID: 32706553
    [No Abstract]   [Full Text] [Related]  

  • 17. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].
    Zhao JP; Hu Y; Du RH; Chen ZS; Jin Y; Zhou M; Zhang J; Qu JM; Cao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):183-184. PubMed ID: 32164084
    [No Abstract]   [Full Text] [Related]  

  • 19. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.
    Taboada M; Caruezo V; Naveira A; Atanassoff PG
    J Clin Anesth; 2020 Nov; 66():109926. PubMed ID: 32474331
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
    Nicolau DV; Bafadhel M
    Lancet Respir Med; 2020 Sep; 8(9):846-847. PubMed ID: 32738928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.